FDG-PET/CT for cardiovascular disease: A systems-level imaging framework linking inflammation, metabolism, and neural
Nobuhiro Tahara1, Atsuko Tahara1, Akihiro Honda1
1Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Insights
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) offers a systems-level view of Atherosclerotic cardiovascular disease (ACVD) by assessing inflammation across multiple organs. This imaging approach aids in risk stratification and personalizing therapies for ACVD.
Area of Science:
- Cardiovascular Imaging
- Inflammatory Diseases
- Molecular Imaging
Background:
- Atherosclerotic cardiovascular disease (ACVD) is a complex chronic inflammatory disorder.
- Conventional imaging lacks insight into ACVD's inflammatory activity.
- A systems-level perspective is needed for understanding ACVD pathophysiology.
Purpose of the Study:
- To review the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in assessing multi-organ inflammation in ACVD.
- To highlight FDG-PET/CT's potential in risk stratification and personalized therapy.
- To discuss FDG-PET/CT as a tool for monitoring therapeutic responses.
Main Methods:
- Utilizes 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for noninvasive assessment.
- Evaluates metabolic activity associated with inflammation in vivo.
- Examines inflammatory processes in vascular plaques, adipose tissue, hematopoietic organs, and neural circuits.
Main Results:
- Increased FDG uptake in various tissues correlates with cardiovascular risk and plaque instability.
- FDG-PET/CT provides quantitative assessment of inflammation.
- FDG-PET/CT enables simultaneous evaluation of systemic inflammatory processes.
Conclusions:
- FDG-PET/CT offers a systems-level imaging framework for ACVD.
- This modality can improve risk stratification and guide personalized therapeutic strategies.
- FDG-PET/CT is valuable for monitoring anti-inflammatory treatment effects.
Abstract:
Atherosclerotic cardiovascular disease (ACVD) is increasingly recognized as a chronic inflammatory disorder involving complex interactions across vascular, metabolic, immune, and neurobiological systems. Conventional imaging modalities primarily assess anatomical features of atherosclerosis but provide limited insight into underlying inflammatory activity. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) enables noninvasive, quantitative assessment of metabolic activity associated with inflammation in vivo. Beyond vascular plaques, FDG-PET/CT can simultaneously evaluate inflammatory processes in adipose tissue, hematopoietic organs, and stress-related neural circuits, offering a systems-level perspective of disease pathophysiology. Accumulating evidence demonstrates that increased FDG uptake in these tissues is associated with cardiovascular risk, plaque instability, and adverse clinical outcomes. Moreover, FDG-PET/CT has emerged as a valuable tool for monitoring therapeutic responses, providing insights into the anti-inflammatory effects of pharmacological interventions. This review summarizes current evidence on the role of FDG-PET/CT in assessing multi-organ inflammatory processes in ACVD and highlights its potential to improve risk stratification and guide personalized therapeutic strategies through a systems-level imaging framework.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies for Cardiovascular System V: CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies for Cardiovascular System IV: CMRI
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
